Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

PMD
Psychemedics Corporation
stock NASDAQ

Inactive
Dec 12, 2024
2.67USD-1.838%(-0.05)113,627
Pre-market
0.00USD-100.000%(-2.72)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 10, 2021
05:00PM EST  Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced that it has declared a cash dividend of $0.05 per share to be paid on December 30th, 2021 to shareholders of record as of December 20th, 2021.   GlobeNewswire Inc
Nov 12, 2021
05:00PM EST  Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2021.   GlobeNewswire Inc
Sep 23, 2021
08:49AM EDT  Peter H. Kamin On Sept. 23 Delivered Letter To Psychemedics Corp's Board Of Directors Stating That It Is Necessary For Psychemedics' Board To Consider Strategic Alternatives For The Benefit Of All Stockholders   Benzinga
Sep 8, 2021
07:32AM EDT  The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod   Benzinga
Aug 10, 2021
02:42PM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Jul 26, 2021
05:15PM EDT  Sundial Growers, MedMen, World Acceptance Among Top Cannabis Stock Movers On July 26, 2021   Benzinga
Jun 22, 2021
05:23PM EDT  Cannabis Stock Gainers And Losers From June 22, 2021   Benzinga
Jun 18, 2021
07:46AM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Jun 17, 2021
04:43PM EDT  Cannabis Stock Gainers And Losers From June 17, 2021   Benzinga
Jun 15, 2021
08:07AM EDT  The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda   Benzinga
Jun 11, 2021
05:13PM EDT  Cannabis Stock Gainers And Losers From June 11, 2021   Benzinga
May 10, 2021
05:16PM EDT  Psychemedics Q1 EPS $0.01 Up From $(0.03) YoY, Sales $5.70M Down From $7.54M YoY   Benzinga
05:15PM EDT  Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2021.   GlobeNewswire Inc
Mar 23, 2021
05:17PM EDT  Psychemedics Q4 EPS $(0.10) Down From $0.06 YoY, Sales $5.33M Down From $8.71M YoY   Benzinga
05:15PM EDT  Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced fourth quarter and full year financial results for the period ended December 31, 2020.   GlobeNewswire Inc
Mar 17, 2021
02:38PM EDT  Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics Corporation effective immediately. Ms. Davis will be filling the vacancy created by the untimely passing this past December of Clint Allen, a long- time and dedicated Psychemedics board member.   GlobeNewswire Inc
Jan 26, 2021
03:28PM EST  Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek has joined the Company as Vice President, Controller.   GlobeNewswire Inc
Dec 17, 2020
10:31AM EST  Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel.   GlobeNewswire Inc
Oct 30, 2020
08:09AM EDT  The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts   Benzinga
Oct 29, 2020
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
Oct 27, 2020
08:25AM EDT  The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings   Benzinga
Aug 12, 2020
05:20PM EDT  Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2020.   GlobeNewswire Inc
Jul 30, 2020
05:44PM EDT  Cannabis Stock Gainers And Losers From July 30, 2020   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC